A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors-Reference-Cited by-同舟云学术

A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors

Published:2012-07-31 Issue:3 Volume:31 Page:685-695
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Mortazavi Amir,Ling Yonghua,Martin Ludmila Katherine,Wei Lai,Phelps Mitch A.,Liu Zhongfa,Harper Erica J.,Ivy S. Percy,Wu Xin,Zhou Bing-Sen,Liu Xiyong,Deam Deidre,Monk J. Paul,Hicks William J.,Yen Yun,Otterson Gregory A.,Grever Michael R.,Bekaii-Saab Tanios

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-012-9863-1.pdf

Reference47 articles.

1. Bokemeyer C et al (1999) Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer. J Clin Oncol 17(2):512–516

2. Burris HA 3rd et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15(6):2403–2413

3. Cardenal F et al (1999) Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 17(1):12–18

4. Heinemann V (2003) Role of gemcitabine in the treatment of advanced and metastatic breast cancer. Oncology 64(3):191–206

5. Markman M (2002) Second-line treatment of ovarian cancer with single-agent gemcitabine. Semin Oncol 29(1 Suppl 1):9–10

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-delivery of gemcitabine and Triapine by calcium carbonate nanoparticles against chemoresistant pancreatic cancer;International Journal of Pharmaceutics;2023-04

2. Antiproliferative Activity and DNA Interaction Studies of a Series of N4,N4-Dimethylated Thiosemicarbazone Derivatives;Molecules;2023-03-20

3. New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer;International Journal of Molecular Sciences;2022-11-13

4. Screening of traditional Chinese medicine monomers as ribonucleotide reductase M2 inhibitors for tumor treatment;World Journal of Clinical Cases;2022-11-06

5. The Role of Iron in DNA and Genomic Instability in Cancer, a Target for Iron Chelators That Can Induce ROS;Applied Sciences;2022-10-10